首页|间充质干细胞源性外泌体在糖尿病肾病中的自噬调节和治疗潜力

间充质干细胞源性外泌体在糖尿病肾病中的自噬调节和治疗潜力

扫码查看
糖尿病肾病(DN)是糖尿病的并发症之一,伴有严重的微血管病变,也是终末期慢性肾脏病的最常见诱导因素。传统的DN治疗方式不能从根本上治愈糖尿病及其并发症,新的治疗方法亟待探索。当前,使用间充质干细胞源性外泌体(MSCs-exo)的诊疗策略已成为DN早期诊断及临床治疗的研究热点。多项研究证实,MSCs-exo在DN治疗中具有较高的有效性和安全性,MSCs-exo通过将自身携带的内容物转移到组织受损部位,在DN模型中发挥肾脏保护作用。该文重点介绍MSCs-exo通过调控细胞自噬在DN发生、发展中的研究进展和治疗潜力,以期为DN的治疗提供新的思路和方法。
Autophagy regulation and therapeutic potential of mesenchymal stem cells-derived exosomes in diabetic nephropathy
Diabetic nephropathy (DN) is one of the complications of diabetes mellitus,which is accom-panied by severe microvascular lesions.and is also the most common inducing factor of end-stage chronic kid-ney disease.The traditional treatment of DN cannot fundamentally cure diabetes and its complications,and new treatment methods need to be explored urgently.At present,the diagnosis and treatment strategy of using mesenchymal stem cells-derived exosomes (MSCs-exo) has become a research hotspot in the early diagnosis and clinical treatment of DN.A number of studies have confirmed that MSCs-exo has high efficacy and safety in the treatment of DN,and MSCs-exo plays a renoprotective role in diabetic nephropathy models by transfer-ring its own contents to the damaged tissue.This article focuses on the research progress and therapeutic po-tential of mesenchymal stem cell-derived exosomes in regulating autophagy in diabetic nephropathy,in order to provide new ideas and methods for the treatment of DN.

diabetic nephropathymesenchymal stem cells-derived exosomesautophagy

吴莉莉、曾今诚

展开 >

广东医科大学医学技术学院/广东省医学分子诊断重点实验室,广东东莞 523808

东莞市大朗医院检验科,广东东莞523770

糖尿病肾病 间充质干细胞源性外泌体 自噬

广东省东莞市社会发展科技重点项目

20221800905322

2024

重庆医学
重庆市卫生信息中心,重庆市医学会

重庆医学

CSTPCD
影响因子:1.797
ISSN:1671-8348
年,卷(期):2024.53(9)